ArticleBiosensors2022
Stacked Model-Based Classification of Parkinson's Disease Patients Using Imaging Biomarker Data.
Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
- Hybrid deep learning novel framework for classification of parkinson's disease.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
Abstract
Parkinson's disease (PSD) is a neurological disorder of the brain where nigrostriatal integrity functions lead to motor and non-motor-based symptoms. Doctors can assess the patient based on the patient's history and symptoms; however, the symptoms are similar in various neurodegenerative diseases, such as progressive supranuclear palsy (PSP), multiple system atrophy-parkinsonian type (MSA), essential tremor, and Parkinson's tremor. Thus, sometimes it is difficult to identify a patient's disease based on his or her symptoms. To address the issue, we have used neuroimaging biomarkers to analyze dopamine deficiency in the brains of subjects. We generated the different patterns of dopamine levels inside the brain, which identified the severity of the disease and helped us to measure the disease progression of the patients. For the classification of the subjects, we used machine learning (ML) algorithms for a multivariate classification of the subjects using neuroimaging biomarkers data. In this paper, we propose a stacked machine learning (ML)-based classification model to identify the HC and PSD subjects. In this stacked model, meta learners can learn and combine the predictions from various ML algorithms, such as K-nearest neighbor (KNN), random forest algorithm (RFA), and Gaussian naive Bayes (GANB) to achieve a high performance model. The proposed model showed 92.5% accuracy, outperforming traditional schemes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.